Drug Profile
Research programme: antibacterial therapeutics - Dr Reddy's
Alternative Names: DRF 11057; DRF 12035; DRF 13792; DRF 16048; DRF 6163; DRF 8114; DRF 8129; DRF 8345; DRF 8417; DRL 11286; DRL 11291; DRL-19440; Oxazolidinone antibacterials research programme - Dr Reddy'sLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Class Oxazolidinones
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in India
- 31 Mar 2010 Preclinical development is ongoing
- 08 Feb 2008 Preclinical development is ongoing